Implantable glucose sensors Right now ... Try different brands if your CGM and blood glucose meter don't match well. The accuracy of both devices can vary depending on the brand and model.

GlucoTrack is a medical technology company whose two-year implantable Continuous Blood Glucose Monitoring (CBGM) technology provides discreet, accurate, real-time glucose readings. The company's ...

on Tuesday announced the successful completion of its first in-human clinical study for its Continuous Blood Glucose Monitor or CBGM. This milestone study, which aimed to evaluate the safety of ...

The Company is currently developing a long-term implantable continuous blood glucose monitoring system for people living with diabetes. Glucotrack’s CBGM is a long-term, implantable system that ...

RUTHERFORD, N.J., May 28, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization of novel technologies for people ...

The Company is currently developing a long-term implantable continuous blood glucose monitoring system for people living with diabetes. Glucotrack’s CBGM is a long-term, implantable system that ...

Glucotrack is working on a long-term implantable continuous blood glucose monitoring system that boasts a three-year sensor lifespan, no external wearable components, and minimal calibration ...

Glucotrack’s CBGM is a long-term implantable system with no wearable component, designed for up to three years of continuous, accurate blood glucose monitoring, offering a more convenient and ...

The device employs a similar approach as continuous glucose monitors ... Once the device is implanted, it begins automatically monitoring the patient’s blood pressure and uploading that data ...

similar to microneedles inside continuous glucose monitors used by people with diabetes to track blood glucose. The scientists implanted the device into the skin of rats with diabetes. Diabetes ...

The ability to directly measure blood glucose in real time and on a continuous basis enables a less burdensome approach to glucose monitoring for extended periods of time. The 90-day preclinical ...